ABSTRACT: Α pacient with acute leukemia and her family including four HLA-identical sibüngs were analyzed to select a donor who was not only HLA-but also minor histocompatibility (mH) antigen compatible for allogeneic bone marrow transplantation (BMT) The HLA-A2 restncted mH antigen-specific HA-1, -2, -4, and -5 cytotoxic T-lymphocyte (CTL) clones were used to type the family members for expression of these mH antigens The patient and one HLA-identical sibling were compatible for these mH antigens This sibling was selected as the bone marrow donor The patient engrafted promptly but developed acute and chronic graft-versus-host disease To study the presence of other mH antigen disparities between recipient and donor, host-versus-graft CTL lines and clones were generated by Stimulation of recipient penpheral blood lymphocytes (PBLs) with donor bone marrow cells, and graft-versus-host CTL lines were generated after BMT from the recipient, respectively, and to cells from several other family members T-cell lines, generated from the patient after BMT by Stimulation of recipient-denved PBLs with donor bone marrow cells, exhibited no specific cytotoxicity to donor or recipient cells Chimensm studles after BMT revealed that the PBLs and T-cell lines generated after BMT were of donor ongin CTL lines that were generated from PBLs from the three other HLA-identical siblings in this family by Stimulation with HLA-identical donor bone marrow cells also exhibited cytotoxicity to cells from several family members Our results show that in addition to companbility for HA-1, -2, -4, and -5 between the recipient and the donor, other mH antigen disparities existed between all HLA-identical siblings, lllustrating the high degree of polymorphism of mH antigens and therefore the difficulty of finding mH antigen-compatible donor-recipient pairs even when more than one HLA-identical sibling IS present within a family
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reflect in vivo sensitization of donor Τ cells againsc mH antigens These mH antigens may be sequentially expressed on recipient stimulator cells, e g , due to sequential infections by pathogens that upregulate expression of vanous self-mH antigens In addition, when PBLs from the three other HLA-identical sibhngs were stimulated with irradiated donor BMMNCs, CTL lines were generated that also recogmzed mH antigens expressed on cells from family merabers These results lllustrate multiple mH antigen dispanties between the HLA-identical family members
Despite the presence of host-antidonor cytotoxic reactivity pnor to BMT, no graft rejection oecurred No residual recipient cells were demonstrated in penpheral blood and bone rnarrow collected from the recipient by chimensm studies after BMT These findings were in aecordance with the inability to generate recipient-antidonor CTL lines from posttransplant PBLs, suggesting chat no functtonal alloreactive recipient Τ lymphocytes were present after BMT These findings can be explained by the eradication of recipient-immunocompetent Τ cells by the condmomng regimen [36, 37), by their suppression by Τ cells from the graft {3], or by the posttransplant immunosuppressive therapy [38] Uncomplicated engraftment despite in vitro HvG reactivity pnor to BMT agrees with a previous report [21] in which we desenbe that, in seven of ten HLA-identical donor-recipient pairs, recipient-antidonor CTL lines were generated before BMT None of these patients showed signs of graft failure or graft rejection GvHD was not prevented by matching for expression of the mH antigens HA-1, -2, A, and -5, suggesting that also in the GvH direction additional mH antigen dispanties were present between donor and recipient Our in vitro results with T-cell lines, generated by Stimulation of PBLs collected at several intervals after BMT with recipient pre-BMT BMMNCs, paralleled the in vivo observed GVH reactivity Van Eis et al [39] could not demonstrate a clear correlation between the incidence of GvHD and the abihty, or inability, to generate antihost CTL lines after BMT Together the results reported here and those by Van Eis et al indicate that most donor-recipient pairs are mH antigen disparate, but that there is not necessanly a relation between the abihty, or inability, to generate CTL lines that lyse recipient or donor cells and the oecurrence of GvHD or graft rejection Presently, matching for mH antigens is not feasible due to their number and polymorphism Quantitative, more than merely qualitative, differences in mH antigen-specific T-cell responses between recipients and their potential donors may be corrciated with graft rt jection or GvHD Quantitative difftrenecs may bc estimated by using hmiting dilution assays to deterrmne-CTL or T-helper-cell precursor frequencies as has been desenbed in unrelated HLA-matched donor-recipicnt pairs or ailogeneic responder-stimulator pairs by Kaminski et al [40, 4 1] and Deacock et al [42] , respectively Adapting these protocols to the specific Situation of HLA-identical sibhng BMT, e g , by usmg BMMNCs as stimulator cells, may produce valuable Information
In conclusion, we have analyzed the mH antigen dispanty between HLA-identical and -nonidentical family members of a patitnt with leukemia, and the possibility of finding a sibhng bone marrow donor who was both HLA and mH antigen compatible In addition to compatibihty for the mH antigens HA-1, -2, -4, and -5 between bone marrow donor and recipsent, dispanty for multiple other mH antigens was demonstrated both in the HvG and the GvH directions CTL lines were generated from PBLs from three other HLA identical sib hngs by Stimulation with donor BMMNC s, also recog nizing mH antigens expresseu 1 ο η cells from family members Donor-antirecipient, but no residual recipi ent-antidonor, reactivity was demonstrated at several intervals after BMT In view of these hndings, hnding donor-recipient pairs that are HLA and mH antigen identical is unhkely Quantitative, more than mc-rtly qualitative, differences in the immune responses to mH antigens between recipients and their potential donors may more hkely determme the incidencc or scvtrity of GvHD or graft rejection following Hl A-identical BMT 
